(BCHMF)

$74.45 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing...

Industry: Chemicals
Sector: Basic Materials
Phone: 41 58 595 2021
Fax: 41 58 595 2043
Address:
Hauptstrasse 144, Bubendorf, Switzerland
Fingerlickengood
Fingerlickengood Jun. 6 at 7:55 PM
$CDXS $BCHMF $NVS $ALNY https://www.pharmacytimes.com/view/nla-2025-inclisiran-with-standard-care-provides-rapid-sustained-lowering-of-ldl-c-in-patients-with-recent-acute-coronary-syndrome
1 · Reply
valueforme
valueforme Jun. 5 at 5:40 PM
$BCHMF RIP Peter Grogg. I did not think this can happen so quickly after this post. $CDXS
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 3 at 10:33 PM
$CDXS Sad news....he was probably the only thing standing in the way of the company being sold to a larger pharma company such as $LLY...this could change the dynamics here very quickly if $BCHMF is sold. https://www.newsfilecorp.com/release/254344/Bachem-Mourns-the-Loss-of-Company-Founder-Dr.-H.C.-Peter-Grogg
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:38 PM
$CDXS $BCHMF $NVS $ALNY FYI...."Inclisiran is being developed by The Medicines Company, a subsidiary of Novartis, which licensed the rights to inclisiran from Alnylam Pharmaceuticals."
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:35 PM
$CDXS $BCHMF Let's see where this goes, looks like a near match to me! https://www.biospace.com/press-releases/codexis-landmark-presentations-at-tides-usa-highlight-reproducibility-and-process-simplification-of-the-eco-synthesis-platform-for-manufacturing-sirna
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:29 PM
$CDXS $BCHMF Note the fine print.... https://www.pharmamanufacturing.com/industry-news/news/55292073/bachem-expands-multisite-production-capacities-to-meet-demand-for-peptides-oligonucleotides
0 · Reply
Fingerlickengood
Fingerlickengood May. 20 at 2:18 PM
$CDXS $BCHMF @valueforme "Early access customer testing is on track to initiate in 2024 ahead of an anticipated full commercial launch in 2026." https://www.codexis.com/investors/news-events/press-releases/detail/376/codexis-announces-achievement-of-gram-scale-synthesis-with-its-eco-synthesis-platform
1 · Reply
Fingerlickengood
Fingerlickengood May. 18 at 3:58 PM
$CDXS $BCHMF https://www.hugrik.com/events/551e93da-0e7f-4321-a5ee-e2f174fac124
0 · Reply
Fingerlickengood
Fingerlickengood May. 8 at 8:33 PM
$CDXS $BCHMF $LLY https://cen.acs.org/business/outsourcing/Bachem-Lilly-partner-oligonucleotide-drugs/100/i15
1 · Reply
Fingerlickengood
Fingerlickengood May. 8 at 4:16 PM
$CDXS Food for thought. $BCHMF https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176013539
1 · Reply
Latest News on BCHMF
No data available.
Fingerlickengood
Fingerlickengood Jun. 6 at 7:55 PM
$CDXS $BCHMF $NVS $ALNY https://www.pharmacytimes.com/view/nla-2025-inclisiran-with-standard-care-provides-rapid-sustained-lowering-of-ldl-c-in-patients-with-recent-acute-coronary-syndrome
1 · Reply
valueforme
valueforme Jun. 5 at 5:40 PM
$BCHMF RIP Peter Grogg. I did not think this can happen so quickly after this post. $CDXS
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 3 at 10:33 PM
$CDXS Sad news....he was probably the only thing standing in the way of the company being sold to a larger pharma company such as $LLY...this could change the dynamics here very quickly if $BCHMF is sold. https://www.newsfilecorp.com/release/254344/Bachem-Mourns-the-Loss-of-Company-Founder-Dr.-H.C.-Peter-Grogg
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:38 PM
$CDXS $BCHMF $NVS $ALNY FYI...."Inclisiran is being developed by The Medicines Company, a subsidiary of Novartis, which licensed the rights to inclisiran from Alnylam Pharmaceuticals."
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:35 PM
$CDXS $BCHMF Let's see where this goes, looks like a near match to me! https://www.biospace.com/press-releases/codexis-landmark-presentations-at-tides-usa-highlight-reproducibility-and-process-simplification-of-the-eco-synthesis-platform-for-manufacturing-sirna
0 · Reply
Fingerlickengood
Fingerlickengood May. 24 at 9:29 PM
$CDXS $BCHMF Note the fine print.... https://www.pharmamanufacturing.com/industry-news/news/55292073/bachem-expands-multisite-production-capacities-to-meet-demand-for-peptides-oligonucleotides
0 · Reply
Fingerlickengood
Fingerlickengood May. 20 at 2:18 PM
$CDXS $BCHMF @valueforme "Early access customer testing is on track to initiate in 2024 ahead of an anticipated full commercial launch in 2026." https://www.codexis.com/investors/news-events/press-releases/detail/376/codexis-announces-achievement-of-gram-scale-synthesis-with-its-eco-synthesis-platform
1 · Reply
Fingerlickengood
Fingerlickengood May. 18 at 3:58 PM
$CDXS $BCHMF https://www.hugrik.com/events/551e93da-0e7f-4321-a5ee-e2f174fac124
0 · Reply
Fingerlickengood
Fingerlickengood May. 8 at 8:33 PM
$CDXS $BCHMF $LLY https://cen.acs.org/business/outsourcing/Bachem-Lilly-partner-oligonucleotide-drugs/100/i15
1 · Reply
Fingerlickengood
Fingerlickengood May. 8 at 4:16 PM
$CDXS Food for thought. $BCHMF https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176013539
1 · Reply
Fingerlickengood
Fingerlickengood May. 6 at 11:22 PM
$CDXS $BCHMF
0 · Reply
Fingerlickengood
Fingerlickengood May. 6 at 9:45 PM
$CDXS $BCHMF This is GREAT for both companies! https://informaconnect.com/tides/agenda/2/
0 · Reply
Fingerlickengood
Fingerlickengood May. 6 at 9:30 PM
$CDXS 'commercial contract' ....my guess is $BCHMF https://www.globenewswire.com/news-release/2025/03/24/3047710/24825/en/Codexis-Announces-First-Revenue-Generating-Contract-for-ECO-Synthesis-Manufacturing-Services.html
0 · Reply
Fingerlickengood
Fingerlickengood May. 6 at 9:16 PM
$CDXS $BCHMF https://www.bachem.com/event/tides-usa-2025/
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 11 at 5:07 PM
$CDXS $BCHMF https://d1io3yog0oux5.cloudfront.net/_dac49734998b4bf03b8cfbc929f3909b/codexis/db/1161/12062/file/Codexis_TIDES_Europe_Investor_Summary_Deck.pdf
1 · Reply
Fingerlickengood
Fingerlickengood Apr. 10 at 4:01 PM
$CDXS $BCHMF https://www.bachem.com/articles/peptides/voices-of-bachem-scaling-up-for-success/
0 · Reply
Fingerlickengood
Fingerlickengood Feb. 5 at 7:52 PM
$CDXS $BCHMF $LLY Some real interesting things happening in this field. Bachem and Lilly have a seven year contract to 'scale up' Oligonucleotide Production....Bachem appeared on a joint slide with Codexis at Tides Europe. Now we are waiting for an 'overdue' statement(s) from Codexis on production and clinical trials. How will this play out is the BIG question!? https://www.technologynetworks.com/biopharma/product-news/bachem-signs-seven-year-agreement-with-eli-lilly-to-accelerate-oligonucleotide-production-362384
0 · Reply
Fingerlickengood
Fingerlickengood Feb. 5 at 6:51 PM
$CDXS $BCHMF Both are laser focused! https://pharmaceuticalmanufacturer.media/pharmaceutical-industry-insights/latest-pharmaceutical-manufacturing-industry-insights/sustainable-oligonucleotide-production-industrial-scale/
0 · Reply
Fingerlickengood
Fingerlickengood Feb. 5 at 6:45 PM
$CDXS $NVS $BCHMF I believe Codexis is a M&A target by at least two major pharma companies. https://www.globenewswire.com/fr/news-release/2024/05/14/2881152/24825/en/codexis-presents-groundbreaking-enzymatic-synthesis-data-at-tides-usa-annual-meeting.html
0 · Reply
MarketBeat
MarketBeat Jul. 20 at 11:40 AM
Bachem initiated by Morgan Stanley at underweight. www.marketbeat.com/stocks/OTCMKTS/BCHMF/price-target/ $BCHMF
0 · Reply
MarketBeat
MarketBeat Jun. 26 at 11:45 AM
Bachem initiated by Citigroup Inc. at sell. www.marketbeat.com/stocks/OTCMKTS/BCHMF/price-target/ $BCHMF
0 · Reply